Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The investigation of killer-cell immunoglobulin-like receptors (KIRs) and their HLA ligands in Iranian patients with myasthenia gravis.

Clinical neurology and neurosurgery - 1 Mar 2024

Jalalvand Mobina, Beigmohammadi Fereshteh, Soltani Samaneh, Ehsan Soroush, Rajabkhah Sahebeh, Madreseh Elham, Akhtari Maryam, Jamshidi Ahmadreza, Farhadi Elham, Mahmoudi Mahdi, Nafissi Shahriar

Abstract excerpt

BACKGROUND: Myasthenia gravis (MG) is a disabling disease with the underlying pathophysiology of auto-antibodies attacking the postsynaptic acetylcholine receptors of neuromuscular junctions causing muscle weakness. Natural killer (NK) cells are innate immune cells that play an important regulative role in immune responses. The human killer-cell immunoglobulin-like receptors (KIRs) family is one of the receptors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to HLA Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulins

Share to Ligands

Share to Myasthenia Gravis

Share to Receptors, KIR

Source

Identifiers

PMID: 38422742
DOI: 10.1016/j.clineuro.2024.108171

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The investigation of killer-cell immunoglobulin-like receptors (KIRs) and their HLA ligands in Iranian patients with myasthenia gravis.PMID 38422742Read ↗

Correlation Between the Prevalence of Myasthenia Gravis and the Frequency of Class II Human Leucocyte Antigen Alleles in Various Geographical Locations Around the WorldSemantic proximity Read ↗

HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.Semantic proximity Read ↗

Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.Semantic proximity Read ↗

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].Semantic proximity Read ↗

The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.Semantic proximity Read ↗

HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.Semantic proximity Read ↗

HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis.Semantic proximity Read ↗

Association of HLA-DQA1*0101/2 and DQB1*0502 with Myasthenia Gravis in Southern Iranian PatientsSemantic proximity Read ↗

Association of HLA-DR/DQ polymorphism with myasthenia gravis in Tunisian patients.Semantic proximity Read ↗

Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey.Semantic proximity Read ↗

A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.Semantic proximity Read ↗

Autoimmune rheumatic diseases and their association with killer immunoglobulin-like receptor genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.